Gender cardiology : focus on clinical and pathophysiological peculiarities in women with long COVID syndrome
Long COVID is a clinical syndrome characterized by the persistence or development of symptoms due to COVID-19 at least 12 weeks after initial infection. More than 200 different symptoms have been ascribed to long COVID, the most common being fatigue, shortness of breath, and muscle weakness. Women have a three-fold higher risk of being diagnosed with long COVID, and the symptoms more often described are persistent weakness, chest pain, altered smell and taste, palpitations or muscle pain, as well as neurological, gastrointestinal and rheumatologic symptoms. Long COVID features are influenced by immune function, endothelial dysfunction and sex hormones. Moreover, it leads to systemic dysfunction, so various therapeutic strategies have been explored and still different trials are ongoing, mainly regarding anticoagulation and immuno-modulators. Nowadays the most quoted interventions are focused rehabilitation programs and pharmacological selected treatments in specifical cases. The aim of this review will be focusing the clinical and pathophysiological sex-related peculiarities to understand the different long COVID phenotypes and possibly address a better tailored approach and treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 2023 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Giornale italiano di cardiologia (2006) - 25(2023), 1 vom: 20. Jan., Seite 6-13 |
Sprache: |
Italienisch |
---|
Weiterer Titel: |
Cardiologia di genere: il punto su peculiarità cliniche e fisiopatologiche nelle donne nel long COVID |
---|
Beteiligte Personen: |
Brigido, Silvana [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 25.12.2023 Date Revised 25.12.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1714/4165.41585 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366316583 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366316583 | ||
003 | DE-627 | ||
005 | 20231227141200.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2024 xx |||||o 00| ||ita c | ||
024 | 7 | |a 10.1714/4165.41585 |2 doi | |
028 | 5 | 2 | |a pubmed24n1238.xml |
035 | |a (DE-627)NLM366316583 | ||
035 | |a (NLM)38140991 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ita | ||
100 | 1 | |a Brigido, Silvana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Gender cardiology |b focus on clinical and pathophysiological peculiarities in women with long COVID syndrome |
246 | 3 | 3 | |a Cardiologia di genere: il punto su peculiarità cliniche e fisiopatologiche nelle donne nel long COVID |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.12.2023 | ||
500 | |a Date Revised 25.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Long COVID is a clinical syndrome characterized by the persistence or development of symptoms due to COVID-19 at least 12 weeks after initial infection. More than 200 different symptoms have been ascribed to long COVID, the most common being fatigue, shortness of breath, and muscle weakness. Women have a three-fold higher risk of being diagnosed with long COVID, and the symptoms more often described are persistent weakness, chest pain, altered smell and taste, palpitations or muscle pain, as well as neurological, gastrointestinal and rheumatologic symptoms. Long COVID features are influenced by immune function, endothelial dysfunction and sex hormones. Moreover, it leads to systemic dysfunction, so various therapeutic strategies have been explored and still different trials are ongoing, mainly regarding anticoagulation and immuno-modulators. Nowadays the most quoted interventions are focused rehabilitation programs and pharmacological selected treatments in specifical cases. The aim of this review will be focusing the clinical and pathophysiological sex-related peculiarities to understand the different long COVID phenotypes and possibly address a better tailored approach and treatment | ||
650 | 4 | |a Review | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Manes, Maria Teresa |e verfasserin |4 aut | |
700 | 1 | |a Ingianni, Nadia |e verfasserin |4 aut | |
700 | 1 | |a Lanni, Francesca |e verfasserin |4 aut | |
700 | 1 | |a Cutolo, Ada |e verfasserin |4 aut | |
700 | 1 | |a La Rovere, Maria Teresa |e verfasserin |4 aut | |
700 | 1 | |a Pavan, Daniela |e verfasserin |4 aut | |
700 | 0 | |a a nome dell’Area Cardiologia di Genere dell’Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Giornale italiano di cardiologia (2006) |d 2006 |g 25(2023), 1 vom: 20. Jan., Seite 6-13 |w (DE-627)NLM16119561X |x 1972-6481 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2023 |g number:1 |g day:20 |g month:01 |g pages:6-13 |
856 | 4 | 0 | |u http://dx.doi.org/10.1714/4165.41585 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2023 |e 1 |b 20 |c 01 |h 6-13 |